Status:

COMPLETED

Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye Syndrome

Lead Sponsor:

Medical University of Vienna

Conditions:

Dry Eye Syndrome

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Dry eye syndrome is a highly prevalent ocular disease with an increasing incidence in the elderly population. Topically administered lubricants are the basis for treatment of this disease. However, in...

Eligibility Criteria

Inclusion

  • Men and women aged over 18 years
  • Signed and dated written informed consent.
  • History of dry eye syndrome for at least 3 months
  • Tear Break Up Time (BUT) ≤ 10 seconds or Schirmer I test ≤ 5 mm and ≥ 2mm
  • OSDI (Ocular Surface Disease Index) ≤ 32 and ≥ 13
  • Normal ophthalmic findings except dry eye syndrome, ametropia \< 6 Dpt.
  • No administration of topical lubricants 24 hours before the screening examination

Exclusion

  • Participation in a clinical trial in the 3 weeks preceding the study
  • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
  • Presence or history of a severe medical condition as judged by the clinical investigator
  • Intake of parasympathomimetic or anti-psychotic drugs
  • Wearing of contact lenses
  • Glaucoma
  • Treatment with corticosteroids in the 4 weeks preceding the study
  • Topical treatment with any ophthalmic drug except topical lubricants in the 4 weeks preceding the study
  • Ocular infection or clinically significant inflammation
  • Ocular surgery in the 3 months preceding the study
  • Sjögren's syndrome
  • Stevens-Johnson syndrome
  • History of allergic conjunctivitis
  • Ametropia \>= 6 Dpt
  • Pregnancy, planned pregnancy or lactating
  • Known hypersensitivity to any component of the study medication.
  • Any medical or surgical history, disorder or disease such as acute or chronic severe organic disease
  • Inability to understand the study procedures

Key Trial Info

Start Date :

May 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2013

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01864330

Start Date

May 1 2013

End Date

September 1 2013

Last Update

November 27 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Clinical Pharmacology

Vienna, Vienna, Austria, 1090